Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008)

International Journal of Antimicrobial Agents

Volumn 37, Issue 3, 2011, Pages 210-218

  Matsumoto, Tetsuro ^a   Hamasuna, Ryoichi ^a   Ishikawa, Kiyohito ^b   Takahashi, Satoshi ^c   Yasuda, Mitsuru ^d   Hayami, Hiroshi ^e   Tanaka, Kazushi ^f   Kiyota, Hiroshi ^g   Muratani, Tetsuro ^h   Monden, Koichi ^i,l   Arakawa, Soichi ^j   Yamamoto, Shingo ^k  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h Kyurin Medical Laboratory   (Japan)

ⁱ OKAYAMA UNIVERSITY   (Japan)

^j KOBE UNIVERSITY HOSPITAL   (Japan)

^k HYOGO COLLEGE OF MEDICINE   (Japan)

^l Araki Urological Clinic   (Japan)

more..

Author keywords

Bacterial sensitivity; Cystitis; Escherichia coli; Quinolone resistance; Urinary tract infection

Indexed keywords

CEFCAPENE PIVOXIL; CEFDINIR; CEPHEM DERIVATIVE; CIPROFLOXACIN; LEVOFLOXACIN; METICILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SITAFLOXACIN; TOSUFLOXACIN;

ACUTE DISEASE; ADULT; AGED; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; CYSTITIS; DRUG TREATMENT FAILURE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; STREPTOCOCCUS AGALACTIAE; URINALYSIS; URINE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CEPHALOSPORINS; CYSTITIS; DATA COLLECTION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; HUMANS; JAPAN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; QUINOLONES; URINARY TRACT INFECTIONS;

EID: 79951951239     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.10.032     Document Type: Article

References (22)

1. K. Yamaguchi, A. Ohno Levofloxacin Surveillance Group Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002 Diagn Microbiol Infect Dis 52 2005 135 143 (Pubitemid 40826940)
2. Y. Kumamoto, T. Tsukamoto, M. Matsukawa, Y. Kunishima, T. Hirose, and S. Shigeta Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004): I. Susceptibility distribution Jpn J Antibiot 59 2006 177 200 [in Japanese] (Pubitemid 44098196)
3. K. Yamaguchi, N. Furuya, M. Iwata, N. Watanabe, N. Uehara, and M. Yasujima Surveillance of susceptibility of clinical isolates to gatifloxacin and various antimicrobial agents Jpn J Chemother 53 2005 627 640 (Pubitemid 41723554)
4. K. Yamaguchi, A. Ohno, Y. Ishii, K. Tateda, M. Iwata, and M. Kanda In-vitro susceptibilities to levofloxacin and various antibacterial agents of 18,639 clinical isolates obtained from 77 centers in 2004 Jpn J Antibiot 59 2006 428 451 [in Japanese] (Pubitemid 46212601)
5. K. Yamaguchi, A. Ohno, Y. Ishii, K. Tateda, M. Iwata, and M. Kanda In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007 Jpn J Antibiot 62 2009 346 370 [In Japanese]
6. Committee on Revision of UTI Drug Efficacy Evaluation Standards, Japanese Society of Chemotherapy Guidelines for clinical trials on genitourinary tract infections, version 1 Jpn J Chemother 57 2009 511 525
7. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. 7th ed. Document M7-A7. Wayne, PA: CLSI; 2006.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Document M100-S17. Wayne, PA: CLSI; 2007.
9. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria; approved guideline. Document M45-A. Wayne, PA: CLSI; 2006.
10. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. Document M100-S18. Wayne, PA: CLSI; 2008.
11. T. Ishii, K. Kawamura, K. Aihara, K. Tokunaga, and K. Suzuki Activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections Kanazawa Ika Daigaku Zasshi 29 2004 227 234
12. S. Ishihara, T. Deguchi, I. Shinoda, S. Nezasa, H. Komeda, and S. Hayashi Efficacy and safety of cefdinir against acute uncomplicated cystitis Jpn J Chemother 51 2003 750 757 (Pubitemid 38128800)
13. M. Yasuda Antimicrobial agents for urinary tract infections Intern Med 102 2008 878 883
14. T. Muratani Resistance of bacteria isolated from urinary tract infections to antimicrobial agents and approach to preventing resistance Antibiot Chemother 25 2009 29 39
15. K.G. Naber, G. Schito, H. Botto, J. Palou, and T. Mazzei Surveillance study in Europe and Brazil on clinical aspects and antimicrobial resistance epidemiology in females with cystitis (ARESC): implications for empiric therapy Eur Urol 54 2008 1164 1178
16. Y. Kawada, S. Ishihara, T. Matsui, M. Tsugawa, T. Matsumoto, and K. Watanabe Comparative study on sitafloxacin and levofloxacin in complicated urinary tract infections Jpn J Chemother 56 2008 81 91 (Pubitemid 351662845)
17. Y. Kawada, M. Yasuda, K. Tanaka, K. Monden, S. Akasaka, and T. Egashira Dose-comparative study of sitafloxacin in complicated urinary tract infections Jpn J Chemother 56 2008 92 102 (Pubitemid 351662846)
18. T. Matsumoto, M. Yasuda, S. Arakawa, K. Monden, T. Muratani, and S. Hori Clinical effect of once daily administration of levofloxacin 500 mg in patients with complicated urinary tract infection Jpn J Chemother 57 2009 34 46
19. H. Kanda, Y. Kurosaka, K. Fujikawa, M. Chiba, S. Yamachika, and R. Okumura In vitro and in vivo antibacterial activity of sitafloxacin Jpn J Chemother 56 2008 1 17 (Pubitemid 351662837)
20. Japanese Association of Infectious Diseases/Japanese Society of Chemotherapy. Guidelines for antimicrobial use. Japanese Association of Infectious Diseases/Japanese Society of Chemotherapy; 2005.
21. M. Kouda, H. Matsushima, J. Hashiguchi, and T. Takahashi Investigation of fluoroquinolone resistant Escherichia coli isolated from urine Jpn J Urol Surg 22 2009 71 77
22. H. Arslan, O.K. Azap, O. Ergönül, F. Timurkaynak Urinary Tract Infection Study Group Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey J Antimicrob Chemother 56 2005 914 918 (Pubitemid 41631917)